Cargando…
Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great effort is being made to understand the disease pathogenesis and host factors that predispose to disease progression in an attempt to find a window of opportunity for intervention. In addition to the direct cyt...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349555/ https://www.ncbi.nlm.nih.gov/pubmed/32423059 http://dx.doi.org/10.3390/vaccines8020224 |
_version_ | 1783557081926729728 |
---|---|
author | Lega, Sara Naviglio, Samuele Volpi, Stefano Tommasini, Alberto |
author_facet | Lega, Sara Naviglio, Samuele Volpi, Stefano Tommasini, Alberto |
author_sort | Lega, Sara |
collection | PubMed |
description | As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great effort is being made to understand the disease pathogenesis and host factors that predispose to disease progression in an attempt to find a window of opportunity for intervention. In addition to the direct cytopathic effect of the virus, the host hyper-inflammatory response has emerged as a key factor in determining disease severity and mortality. Accumulating clinical observations raised hypotheses to explain why some patients develop more severe disease while others only manifest mild or no symptoms. So far, Covid-19 management remains mainly supportive. However, many researches are underway to clarify the role of antiviral and immunomodulating drugs in changing morbidity and mortality in patients who become severely ill. This review summarizes the current state of knowledge on the interaction between SARS-CoV-2 and the host immune system and discusses recent findings on proposed pharmacologic treatments. |
format | Online Article Text |
id | pubmed-7349555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73495552020-07-14 Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 Lega, Sara Naviglio, Samuele Volpi, Stefano Tommasini, Alberto Vaccines (Basel) Review As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great effort is being made to understand the disease pathogenesis and host factors that predispose to disease progression in an attempt to find a window of opportunity for intervention. In addition to the direct cytopathic effect of the virus, the host hyper-inflammatory response has emerged as a key factor in determining disease severity and mortality. Accumulating clinical observations raised hypotheses to explain why some patients develop more severe disease while others only manifest mild or no symptoms. So far, Covid-19 management remains mainly supportive. However, many researches are underway to clarify the role of antiviral and immunomodulating drugs in changing morbidity and mortality in patients who become severely ill. This review summarizes the current state of knowledge on the interaction between SARS-CoV-2 and the host immune system and discusses recent findings on proposed pharmacologic treatments. MDPI 2020-05-14 /pmc/articles/PMC7349555/ /pubmed/32423059 http://dx.doi.org/10.3390/vaccines8020224 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lega, Sara Naviglio, Samuele Volpi, Stefano Tommasini, Alberto Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 |
title | Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 |
title_full | Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 |
title_fullStr | Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 |
title_full_unstemmed | Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 |
title_short | Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19 |
title_sort | recent insight into sars-cov2 immunopathology and rationale for potential treatment and preventive strategies in covid-19 |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349555/ https://www.ncbi.nlm.nih.gov/pubmed/32423059 http://dx.doi.org/10.3390/vaccines8020224 |
work_keys_str_mv | AT legasara recentinsightintosarscov2immunopathologyandrationaleforpotentialtreatmentandpreventivestrategiesincovid19 AT navigliosamuele recentinsightintosarscov2immunopathologyandrationaleforpotentialtreatmentandpreventivestrategiesincovid19 AT volpistefano recentinsightintosarscov2immunopathologyandrationaleforpotentialtreatmentandpreventivestrategiesincovid19 AT tommasinialberto recentinsightintosarscov2immunopathologyandrationaleforpotentialtreatmentandpreventivestrategiesincovid19 |